Breaking News Instant updates and real-time market news.

GPRE

Green Plains

$16.94

-0.23 (-1.34%)

, GPP

Green Plains Partners

$14.68

(0.00%)

10:46
11/15/18
11/15
10:46
11/15/18
10:46

Green Plains announces permanent closure of Hopewell, VA ethanol facility

Green Plains (GPRE) announced that it is permanently closing its Hopewell, VA ethanol facility. A significant portion of the 60 million gallon a year capacity plant will be dismantled during the decommissioning process, with most of the equipment being transferred to other Green Plains facilities. The company is also currently determining the best uses for any remaining equipment and the land. The closure results in a workforce reduction of approximately 31 employees who will be provided severance and healthcare support. A handful of staff will remain to oversee the decommissioning of the plant, which is expected to take 12 to 18 months. For Green Plains Partners LP (GPP), the closure of the Hopewell plant does not change the quarterly minimum volume commitment associated with the ethanol storage and throughput agreement between Green Plains Inc. and Green Plains Partners.

GPRE

Green Plains

$16.94

-0.23 (-1.34%)

GPP

Green Plains Partners

$14.68

(0.00%)

GPRE Green Plains
$16.94

-0.23 (-1.34%)

10/11/18
SPHN
10/11/18
NO CHANGE
Target $18
SPHN
Equal Weight
Green Plains likely to announce more plant sales this month, says Stephens
After Green Plains (GPRE) announced an agreement to sell three ethanol plants to Valero (VLO) and an agreement to acquire storage and transportation assets from Green Plains Partners (GPP), Stephens analyst Farha Aslam said she sees this as the first step in the company's plan to divest non-core assets to reduce debt. She expects an announcement of two to three more plant sales to come later this month, Aslam added. The deal with Valero, which involves about 20% of Green Plains' reported capacity, is anticipated along with the Partners transaction to be 10c dilutive to FY19 EPS, Aslam estimates. She lowered her price target on Green Plains shares to $18 from $20 and keeps an Equal Weight rating on the stock, citing what she views as "challenging" fundamentals in the ethanol industry.
10/03/18
CHLM
10/03/18
NO CHANGE
CHLM
Buy
Trump's potential waiver for year-round sale of E15 positive for industry, says Craig-Hallum
Commenting on indications that President Trump will ask the EPA next week to grant a waiver for the year-round sale of E15, Craig-Hallum analyst Eric Stine says he believes the chances are high that this will happen given the importance of the farm vote to midterm elections and Trump's re-election prospects. The analyst believes this would be a strong positive for the industry and would positively impact industry demand in 2019. Stine reiterates a Buy rating on Pacific Ethanol (PEIX) and Green Plains (GPRE) shares.
07/31/18
ROTH
07/31/18
NO CHANGE
Target $25
ROTH
Buy
Roth Capital sees selloff in Green Plains as overdone
Roth Capital analyst Craig Irwin sees the selloff in Green Plains as overdone, as ethanol has the clear support of President Trump, and positive policy changes are likely to materialize at some point this year. Short-term volatility with corn prices pressured on trade tensions with China likely benefits Ethanol profits in 2H18, he adds. The analyst reiterates a Buy rating and $25 price target on the shares.
06/28/18
06/28/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AeroVironment (AVAV) downgraded to Hold from Buy at Stifel with analyst Joseph DeNardi citing valuation, but he continues to maintain a positive bias on the stock. 2. Beacon Roofing (BECN) downgraded to Sector Perform from Outperform at RBC Capital with analyst Michael Eisen saying he sees a threat to consensus estimates based on the higher oil price and freight costs amid declining industry demand. 3. Green Plains (GPRE) downgraded to Equal Weight from Overweight at Stephens with analyst Farha Aslam stating that its restructuring plan is a long-term positive, but in the near-term the company may be "forced to cut muscle." 4. Mattel (MAT) downgraded to Underperform from Neutral at DA Davidson with analyst Linda Bolton Weiser noting that the stock price has risen 29% from its April low even though the company's fundamentals have not improved. 5. Aquinox (AQXP) downgraded to Hold from Buy at Needham with analyst Alan Carr noting that the company's Phase 3 trial of rosiptor in Interstitial Cyrstitis failed to demonstrate efficacy, with no evidence of activity at any point or within any subset of patient subset. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
GPP Green Plains Partners
$14.68

(0.00%)

05/08/18
05/08/18
DOWNGRADE
Target $17

Neutral
Green Plains Partners downgraded to Neutral at Roth Capital
As previously reported, Roth Capital analyst Craig Irwin downgraded Green Plains Partners to Neutral from Buy, with a $17 price target, on parent portfolio adjustment.
05/08/18
ROTH
05/08/18
DOWNGRADE
ROTH
Neutral
Green Plains Partners downgraded to Neutral from Buy at Roth Capital
02/09/18
02/09/18
UPGRADE
Target $20

Buy
Green Plains Partners upgraded to Buy after pullback at Stifel
As previously reported, Stifel analyst Selman Akyol upgraded Green Plains Partners to Buy from Hold following the recent pullback in the units. Q4 results topped his expectations and management reiterated their intention to grow the distribution at 8-10% annually, noted Akyol, who maintains his $20 price target on Green Plains Partners.

TODAY'S FREE FLY STORIES

NVS

Novartis

$75.84

0.42 (0.56%)

05:38
04/24/19
04/24
05:38
04/24/19
05:38
Earnings
Novartis raises FY19 core operating income view to high single-digit growth »

Expects FY19 revenue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

NVS

Novartis

$75.84

0.42 (0.56%)

05:36
04/24/19
04/24
05:36
04/24/19
05:36
Earnings
Novartis reports Q1 core EPS $1.21, consensus $1.20 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

VBIV

VBI Vaccines

$2.00

0.05 (2.56%)

05:34
04/24/19
04/24
05:34
04/24/19
05:34
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 23

    May

PLCE

Children's Place

$109.92

2.95 (2.76%)

05:34
04/24/19
04/24
05:34
04/24/19
05:34
Initiation
Children's Place initiated  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAC

TransAlta

$6.88

-0.175 (-2.48%)

05:32
04/24/19
04/24
05:32
04/24/19
05:32
Hot Stocks
TransAlta comments on Mangrove Partners release, urges holders to vote BLUE card »

TransAlta commented on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CRI

Carter's

$105.13

2.02 (1.96%)

05:31
04/24/19
04/24
05:31
04/24/19
05:31
Initiation
Carter's initiated  »

Carter's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 16

    May

STRL

Sterling Construction

$13.77

0.19 (1.40%)

05:30
04/24/19
04/24
05:30
04/24/19
05:30
Hot Stocks
Sterling Construction awarded $23M contract by UDOT »

Sterling Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

COST

Costco

$245.56

2.1 (0.86%)

05:27
04/24/19
04/24
05:27
04/24/19
05:27
Recommendations
Costco analyst commentary at Baird »

Costco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 30

    May

EBAY

eBay

$36.66

0.51 (1.41%)

05:22
04/24/19
04/24
05:22
04/24/19
05:22
Recommendations
eBay analyst commentary  »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$262.32

1.39 (0.53%)

05:19
04/24/19
04/24
05:19
04/24/19
05:19
Recommendations
Abiomed analyst commentary at Piper Jaffray »

CMS proposed rate changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 05

    Jun

  • 13

    Nov

MMSI

Merit Medical

$59.13

1.57 (2.73%)

05:16
04/24/19
04/24
05:16
04/24/19
05:16
Recommendations
Merit Medical analyst commentary at Piper Jaffray »

Piper calls Merit Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

  • 23

    May

HOLX

Hologic

$44.26

1.26 (2.93%)

05:13
04/24/19
04/24
05:13
04/24/19
05:13
Recommendations
Hologic analyst commentary at Piper Jaffray »

Hologic checks suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 07

    May

  • 29

    May

  • 05

    Jun

SYK

Stryker

$186.95

4.905 (2.69%)

05:09
04/24/19
04/24
05:09
04/24/19
05:09
Recommendations
Stryker analyst commentary at Piper Jaffray »

Stryker's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 08

    May

  • 29

    May

ICLK

iClick Interactive Asia

$3.89

-0.115 (-2.87%)

05:08
04/24/19
04/24
05:08
04/24/19
05:08
Hot Stocks
iClick enters marketing technology joint venture with VGI »

VGI Global Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$36.66

0.51 (1.41%)

05:05
04/24/19
04/24
05:05
04/24/19
05:05
Recommendations
eBay analyst commentary  »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$38.92

-0.79 (-1.99%)

05:03
04/24/19
04/24
05:03
04/24/19
05:03
Downgrade
Harley-Davidson rating change  »

Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

BBY

Best Buy

$73.60

1 (1.38%)

05:02
04/24/19
04/24
05:02
04/24/19
05:02
Upgrade
Best Buy rating change at Jefferies »

Best Buy upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

FOJCY

Fortum

$0.00

(0.00%)

05:00
04/24/19
04/24
05:00
04/24/19
05:00
Upgrade
Fortum rating change  »

Fortum upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGLOY

Anglo American

$0.00

(0.00%)

04:58
04/24/19
04/24
04:58
04/24/19
04:58
Downgrade
Anglo American rating change  »

Anglo American downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$11.99

0.46 (3.99%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Upgrade
Snap rating change at JPMorgan »

Snap upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PIRS

Pieris Pharmaceuticals

$2.93

0.01 (0.34%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Pieris Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

MPSYF

Morphosys AG

$0.00

(0.00%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Morphosys AG management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

MOR

MorphoSys

$24.78

0.7 (2.91%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
MorphoSys management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

  • 20

    Jun

NTGN

Neon Therapeutics

$6.21

0.03 (0.49%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Neon Therapeutics management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

AXU

Alexco Resource

$0.96

-0.0396 (-3.98%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
Alexco Resource management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.